Position in CNMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,445,745
-$8,487,937 QoQ
Shares Held
441,361
-31.9% QoQ
Ownership
1.47%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#19
of 246 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CNMD Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $389,929,701 across 26 Medical Devices names. CNMD ranks #9 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
940,395 | $85,331,442 | |
| 2 | SYK |
Stryker Corp
|
182,236 | $57,375,182 | |
| 3 | HAE |
Haemonetics Corp
|
493,796 | $37,034,700 | |
| 4 | ITGR |
Integer Holdings Corp
|
371,484 | $34,715,179 | |
| 5 | AORT |
Artivion, Inc.
|
1,024,091 | $23,011,324 | |
| 6 | BSX |
Boston Scientific Corp
|
461,588 | $19,700,575 | |
| 7 | SIBN |
SI-BONE, Inc.
|
1,158,576 | $18,907,960 | |
| 8 | GKOS |
GLAUKOS Corp
|
121,880 | $17,033,948 |
All Filings in CNMD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,445,745 | 441,361 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,933,682 | 648,577 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,191,065 | 866,775 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $50,498,180 | 1,073,744 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $44,369,295 | 851,945 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $62,540,125 | 1,035,604 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $68,489,208 | 1,000,719 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||